Preclinical antiarthritic activity of matrix metalloproteinase inhibitors.
SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406-0939.
M J
MJ
DiMartino
W
W
High
W A
WA
Galloway
M J
MJ
Crimmin
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001169:Arthritis, Experimental / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D007213:Indomethacin / Q000627:therapeutic use; D007249:Inflammation; D007536:Isomerism; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011859:Radiography; D051381:Rats; D013876:Thiophenes / Q000627:therapeutic use*; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D013876:Thiophenes; D010649:Phenylalanine; C080985:batimastat; D008666:Metalloendopeptidases; D007213:Indomethacin